Pharmaceutical Costs

Pharmaceutical prices are rising, driving up premiums and out-of-pocket costs. Today, 21 percent of spending in employer-sponsored plans goes to retail prescription drugs.[i] State budgets – that by law, have to be balanced- are reeling from high and unpredictable pharmaceutical increases for corrections, state employees and retirees, K-12 and public university employees, and, of course, […]

Read More
  • Webinars

    In this webinar, members of the National Academy for State Health Policy’s Pharmacy Costs Workgroup review 11 specific proposals for how states may curb the rising cost of pharmaceuticals. NASHP’s work group looks broadly at states as purchasers, regulators, policymakers, and investors to develop the next generation of state–based reforms to address the rapid growth […]

    Read More
  • States and the Rising Cost of Pharmaceuticals: A Call to Action
    Publications

    As part of the 29th Annual State Health Policy Conference, held 17-19 in Pittsburgh, PA, NASHP released findings from our Pharmacy Costs Work Group aimed at addressing the increasingly rising costs of pharmaceuticals.  The solutions offered in the newly released findings serve as a toolbox for states. While they recognize the value of the pharmaceutical industry, state policymakers […]

    Read More
  • New Findings from Rx Work Group Released at National Health Event Pittsburgh, PA – The National Academy for State Health Policy (NASHP) today released findings from their Pharmacy Costs Work Group aimed at addressing the increasingly rising costs of pharmaceuticals. The findings were released as part of their 29th Annual State Health Policy Conference, held […]

    Read More
  • State Legislative Action on Pharmaceutical Prices
    Maps

    *Updated August 9, 2017* As part of our Pharmacy Cost Work Group, an ongoing project that looks beyond the strategies currently used in states to identify and develop new ideas which address the growing problem of prescription drug costs, NASHP has been tracking state legislative actions to control the rising cost of prescription drugs. This series of […]

    Read More
  • The newly launched National Academy for State Health Policy (NASHP) Pharmacy Cost Work Group will look beyond the strategies currently used in states to identify and develop new ideas which address the growing problem of Rx costs. The group will look broadly at states as purchasers, regulators, policymakers, and investors to develop the next generation […]

    Read More
  • State Health Policy Blog

    Governor Paul LePage signed into law “An Act to Prevent Opiate Abuse by Strengthening the Controlled Substances Prescription Monitoring Program” (now PL 2015, c. 488) on April 19, 2016, making Maine the second state to pass legislation on the issue this year. In March, Massachusetts passed the nation’s first law limiting first-time opioid prescriptions. Maine’s […]

    Read More
  • Publications

    States are significant purchasers of health care for Medicaid, inmates in correctional facilities, and public employees. Despite considerable efforts to maintain affordability, drug pricing continues to vex state budgets. While Medicaid is the largest single health expenditure in state budgets, spending on health care for public workers including state employees and retirees, legislators, judicial employees, […]

    Read More